Diseases, Conditions, Syndromes

Covid treatments: still struggling for mass uptake

Several treatments are now available to fight COVID-19 but tight timelines, unequal access and weakening effectiveness against new variants have limited their ability to blunt the worst of the pandemic.

Medications

Senators unveil compromise to reduce drug costs for seniors

Two senior senators—a Republican and a Democrat—unveiled compromise legislation Tuesday to reduce prescription drug costs for millions of Medicare recipients, while saving money for federal and state health care programs ...

Oncology & Cancer

New treatment for non-Hodgkin lymphoma approved

(HealthDay)—Poteligeo (mogamulizumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with two types of non-Hodgkin lymphoma.

Medications

States seek to expand lawsuit against generic drugmakers

Connecticut's attorney general and 45 of his colleagues are seeking to expand a federal antitrust lawsuit against generic drugmakers to include more manufacturers and medications, as well as senior executives at two companies.

Medications

High court sides with drugmaker in Plavix lawsuit

The Supreme Court says hundreds of out-state-residents can't sue drugmaker Bristol-Myers Squibb Co. in California state court over adverse reactions to the blood thinner Plavix.

Medications

Generic drugmakers want antitrust lawsuit dismissed

Six generic drugmakers are asking a federal judge in Connecticut to dismiss a 40-state lawsuit accusing them of artificially inflating and manipulating prices to reduce competition for antibiotic and oral diabetes medication.

page 1 from 4